{
  "$schema": "folio-library-entry/v1",
  "id": "10665-266967",
  "blocks": [
    {
      "id": "library/10665-266967/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 2,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "Bull. Org. mond. Sante\n1963, 29, 323-330\nBull. Wld Hlth Org.\nThe Value of Duck-embryo Vaccine\nand High-Egg-Passage Flury Vaccine in Experimental\nRabies Infection in Guinea-pigs\nN. VEERARAGHAVAN, M.B.B.S., D.Sc.' & T. P. SUBRAHMANYAN, M.Sc.2\nThe authors have compared the value of multiple doses ofduck-embryo and HEP Flury\nvaccine with that of pooled 5 % sheep-brain vaccine in experimental rabies infection in\nguinea-pigs.\nThey found that the duck-embryo vaccine given in a dosage corresponding\nto 14 ml of 10 % vaccine (the dosage recommended for human treatment), either alone\nor with antirabies s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The opening of a 1963 Bulletin article by Veeraraghavan and Subrahmanyan comparing duck-embryo and HEP Flury rabies vaccines with pooled sheep-brain vaccine in guinea-pigs. The abstract reports that the avian embryo vaccines gave little protection after infection, even at high doses, while pooled phenolized vaccine worked well. It concludes that the recommended human dose of duck-embryo vaccine is inadequate and HEP Flury vaccine is unsuited for post-infection treatment, before reviewing earlier work on the duck-embryo vaccine.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "VEERARAGHAVAN & T. P. SUBRAHMANYAN",
      "pageStart": 2,
      "pageEnd": 2,
      "target": "../sections/sec-000-n-veeraraghavan-t-p-subrahmanyan.md",
      "narrative": null,
      "content": "N. VEERARAGHAVAN & T. P. SUBRAHMANYAN\nthe pre- and post-infection treatment of guinea-pigs\nunder standard conditions.\nThere has been considerable interest in the high-\negg-passage (HEP) Flury live-virus vaccine developed",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A fragment noting interest in the high-egg-passage Flury live-virus rabies vaccine.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "by",
      "pageStart": 2,
      "pageEnd": 2,
      "target": "../sections/sec-001-by.md",
      "narrative": null,
      "content": "mining its suitability for human treatment, a large\nnumber of studies have been carried out to assess\nthe serum antibody response elicited by the vaccine\n(Schwab et al., 1954; Fox, 1958; Schnurrenberger\net\nal.; 1 Ruegsegger et\nal.; 2 Sharpless; 3 Tierkel\net al.; 4Ruegsegger et al., 1961; Schnurrenberger\net al., 1961; Tierkel, 1962). We have reported earlier\nthat a single dose of HEP Flury vaccine given\nwith antirabies serum is not of much value in the\npost-infection treatment though, given alone 12 days\nbefore challenge, it could induce solid immunity in\nguinea-pigs (Veeraraghavan et al.,\n1957",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reviews antibody studies of HEP Flury vaccine and the authors' earlier findings, then explains that multiple doses of each vaccine were tested before and after challenge with pooled vaccine as control. The methods begin with the guinea-pigs used.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "employed",
      "pageStart": 2,
      "pageEnd": 3,
      "target": "../sections/sec-002-employed.md",
      "narrative": null,
      "content": "for serum\nneutralization and\nvaccine\npotency tests were bred at the Institute from the\nRockefeller Institute strain.\nChallenge virus\nThe dog (D.266/56) strain of street virus was used\nin the street virus experiments. The material em-\nployed\nwas\nthe\nlyophilized\nsubmaxillary\ngland\nsuspension of a dog infected in nature. The methods\nof administering the challenge and of determining\nthe number of LD50 used in each experiment were\n1 Schnurrenberger, P. R., Sharpless, G. R., Anderson,\nG., Powell, H. M. & Peck, F. B., Jr (1959) Comparative\nSN antibody studies on persons inoculated with intradermal\ndu",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the methods, including the mice used, the dog street-virus challenge strain, the mouse potency test and the two antirabies sera with their dilutions. It also gives the dosage schedules for the duck-embryo vaccine.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "and",
      "pageStart": 3,
      "pageEnd": 3,
      "target": "../sections/sec-003-and.md",
      "narrative": null,
      "content": "amount given to the same level as in the case of\nphenolized vaccine.\nThe\nduck-embryo\nvaccine\nwas\nalways\ngiven\nsubcutaneously.\nHEP Flury vaccine\nLederle's high-egg-passage chicken-embryo-adapt-\ned\nrabies\nvaccine,\nlots\nNo.\n7-1173-218B\nand\nNo. 7-1173-229A, were used in the first and second\nexperiments respectively.\nThe vaccine was reconstituted with 2.4 ml of\nphysiological saline to give a 35 % suspension, with-\ndrawn from the vials and diluted to 5 % tissue con-\ncentration, kept in ice and used within an hour. Two\ndosage schedules, 14 x 0.015 ml and 14 x 0.075 ml,\nwere employed, the former corre",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how the HEP Flury vaccine was reconstituted and given in two dosage schedules, and introduces the pooled phenolized vaccine.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "method",
      "pageStart": 3,
      "pageEnd": 4,
      "target": "../sections/sec-004-method.md",
      "narrative": null,
      "content": "described\nby\nVeeraraghavan (1959) was used. On the basis of\nour\nearlier work,\nthe vaccine\nwas administered\nsubcutaneously in 14 daily doses of 0.075 ml.\nPeriod of observation\nGuinea-pigs were observed for a minimum period\nof 6 months and mice for 30 days after challenge.\nDiagnosis\nFor each death, a diagnosis was established by\napproved methods,\nincluding fluorescence micro-\nscopy and animal inoculation test, wherever indi-\ncated.\nRESULTS\nIn the first two experiments reported here,\nan\nattempt has been made to determine if the avian\nembryo vaccines compare favourably with pooled\nvaccine when giv",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Completes the methods with the pooled vaccine schedule, observation periods and diagnosis of deaths. It outlines the three experiments and presents Experiment 1 results in a table of deaths after treatment with each vaccine alone or with serum.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "VEERARAGHAVAN &",
      "pageStart": 4,
      "pageEnd": 4,
      "target": "../sections/sec-005-n-veeraraghavan.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "P. SUBRAHMANYAN",
      "pageStart": 4,
      "pageEnd": 4,
      "target": "../sections/sec-006-t-p-subrahmanyan.md",
      "narrative": null,
      "content": "P. SUBRAHMANYAN\nIt was found that 14 x 0.015 ml of duck-embryo\nvaccine failed to give significant protection whether\ngiven alone or with the different doses of serum.\nThe mortality was 100% when the vaccine was given\nalone or with 5 units of serum L.\nWith 14 x 0.015 ml of HEP Flury vaccine, the\nprotection was equally poor whether the vaccine was\ngiven alone or with different doses of serum. The\nhigher dose (14 x 0.075 ml) of HEP Flury vaccine\nfailed to save any animal when given alone, but the\nmortality\nwas only 80% when the vaccine\nwas\nadministered with 10 units of serum PIC.\nIn\ncontrast,\ncom",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports that in Experiment 1 duck-embryo and HEP Flury vaccines gave little or no protection after infection, while pooled phenolized vaccine with serum protected significantly. Experiment 2 is introduced to compare all three vaccines at identical doses, before and after challenge.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Two",
      "pageStart": 4,
      "pageEnd": 5,
      "target": "../sections/sec-007-two.md",
      "narrative": null,
      "content": "additional\ncontrol groups were incorporated in the experiment,\none receiving 25 units of serum L and the other\n10 units of serum PIC alone.\nThe challenge em-\nployed proved to be 73 LD50.\nThe results are summarized in Table 2.\nWhen given in seven doses of 0.3 ml, all the three\nvaccines afforded significant protection against\na\nchallenge given on the eighth day. However, treat-\nment with 7 x 0.3 ml of pooled vaccine was signifi-\ncantly superior to that with the same dose of duck-\nembryo or Flury vaccine, the latter two not differing\nbetween each other in the protection conferred.\nPost-infection",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports that all three vaccines protected when given before challenge, though pooled vaccine did best, while duck-embryo vaccine after infection protected only with one serum. A table gives the Experiment 2 results.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "An",
      "pageStart": 5,
      "pageEnd": 5,
      "target": "../sections/sec-008-an.md",
      "narrative": null,
      "content": "HEP Flury vaccine, given after infection, did not\nsave a significant proportion of animals, whether\ngiven alone or with the different doses of serum.\nCombined therapy with pooled vaccine and 5 or\n25 units of serum L or 10 units of serum PIC con-\nferred significant protection. Treatment with pooled\nvaccine and 5 or 25 units of serum L was significantly\nsuperior to that with the same dose of serum and\nduck-embryo vaccine.\nBut, when serum PIC was",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that HEP Flury vaccine after infection gave no significant protection, while pooled vaccine with serum did, outperforming duck-embryo vaccine.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Although",
      "pageStart": 5,
      "pageEnd": 5,
      "target": "../sections/sec-009-although.md",
      "narrative": null,
      "content": "vaccine gave better survival rates.\nAs in Experi-\nment 1, the best results were obtained with 10 units\nof serum PIC and 14 x 0.075 ml of pooled vaccine.\nThe protection afforded by 14 x 0.075 ml of pooled\nvaccine alone was also significant, while the mortal-\nity rates in the case of duck-embryo and HEP Flury\nvaccines were 85% and 100% respectively.\nSerum alone (25 units of serum L or 10 units of\nserum PIC) failed to protect animals, confirming\nour earlier observations.\nThe results indicate that even when given in\nidentical\ndoses,\npooled\nphenolized\nvaccine\nwas\nsuperior to the other two vaccines,",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports that, as in Experiment 1, pooled vaccine with serum gave the best results while duck-embryo and HEP Flury vaccines had high mortality and serum alone did not protect. It concludes that pooled phenolized vaccine was superior even at identical doses and introduces a mouse potency comparison in Experiment 3.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The ED50",
      "pageStart": 5,
      "pageEnd": 6,
      "target": "../sections/sec-010-the-ed50.md",
      "narrative": null,
      "content": "of the two batches of duck-embryo vaccine and\npooled vaccine used in this study and their antigenic\nvalue with respect to the former NIH reference vac-\ncine 164 were determined.\nThe results are presented in Table 3.\nIt was found that in both the potency tests, the\nduck-embryo vaccines proved to be poorer antigens\nthan the pooled phenolized vaccines. They, however,\npassed the minimum requirements of potency with\nreference to former reference vaccine 164, which had\ndropped considerably\nin potency and had been\nwithdrawn.\nDISCUSSION\nThe studies of several workers indicate that the\nduck-embryo vacc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports that duck-embryo vaccines were weaker antigens than pooled vaccine in mouse potency tests, though they passed against an outdated reference vaccine. The discussion criticizes earlier protection studies of duck-embryo vaccine for using very large doses unrelated to human treatment.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "VEERARAGHAVAN & T. P. SUBRAHMANYAN",
      "pageStart": 6,
      "pageEnd": 6,
      "target": "../sections/sec-011-n-veeraraghavan-t-p-subrahmanyan.md",
      "narrative": null,
      "content": "delaying of the challenge up to 21 days after the\nfirst dose of vaccine could explain the excellent\nresults in the first experiment. When the dosage of",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A fragment saying that large doses and delayed challenge could explain good results in an earlier experiment.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "and",
      "pageStart": 6,
      "pageEnd": 7,
      "target": "../sections/sec-012-and.md",
      "narrative": null,
      "content": "was administered on the tenth day in the second\nexperiment, the results were poorer, the mortality\nbeing 7/23 compared with 0/23 in the first experi-\nment.\n(2) The challenge was given seven days after\nthe completion of treatment in the case of rabbits\nand the first group of guinea-pigs, and on the last\nday of treatment in the case of the second group of\nguinea-pigs.\n(3) The challenge was given intra-\ncerebrally in rabbits. The experience of the senior\nauthor of the present paper has been that the results\nof intracerebral challenge of rabbits with street virus\nare irregular\nand\nare not\nalways\nr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists further flaws in earlier studies, such as timing and route of challenge, few animals and short observation, and explains how the present study avoided them. It argues that the dose of duck-embryo vaccine needed would be unaffordable for countries such as India. The mouse potency results are said to support the protection findings.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "minimum",
      "pageStart": 7,
      "pageEnd": 7,
      "target": "../sections/sec-013-minimum.md",
      "narrative": null,
      "content": "requirement because (a) the challenge was with a\nhomologous virus (namely, the CVS strain) which is\nused in the vaccine production (Anderson et al.,\n1960) and (b) the former NIH reference vaccine 164\nused for comparison has shown a considerable drop\nin potency. Our findings on the poor antigenicity\nof the duck-embryo vaccine are also in agreement\nwith the results reported recently by Dean & Sherman\n(1962). They found that while all the seven lots of\nSemple type nervous tissue vaccines of rabbit origin\npassed the Habel test,\n13 (72.2%) of 18 lots of\nduck-embryo\nvaccine\ndid\nnot\nmeet\nminimum\nrequ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes agreement with other findings that many duck-embryo vaccine lots fail potency requirements, and judges HEP Flury vaccine too poor for post-infection use. The conclusions restate that the recommended human dose of duck-embryo vaccine is inadequate and that nervous tissue vaccines should be replaced only after careful studies.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "ACKNOWLEDGEMENTS",
      "pageStart": 7,
      "pageEnd": 8,
      "target": "../sections/sec-014-acknowledgements.md",
      "narrative": null,
      "content": "Tlhe authors are greatly indebted to Mr R. Rangasami, Mr A. Kulla and Mr M. A. Rajan for their invaluable\nassistance throughout these studies. The authors' grateful thanks are due to WHO for financial assistance.\n329",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Acknowledgements thanking three assistants and WHO for financial support.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "VEERARAGHAVAN &",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/sec-015-n-veeraraghavan.md",
      "narrative": null,
      "content": "N. VEERARAGHAVAN &",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A fragment containing only part of an author name.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "P. SUBRAHMANYAN",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/sec-016-t-p-subrahmanyan.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "RI-SUMt",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/sec-017-ri-sumt.md",
      "narrative": null,
      "content": "L'efficacite de doses multiples de vaccin antirabique\nprepare sur embryon de canard et celle du vaccin Flury\nHEP ont e\ncomparees a celle d'un vaccin phenole a\nbase de cerveau de mouton a 5% dans le traitement de la\nrage experimentale du cobaye. L'on a vu que le vaccin\nprepare sur embryon de canard, administre a une dose\ncorrespondant a 14 ml de vaccin a 10% recommand6e\npour le traitement de la rage humaine ne pouvait, aussi\nbien seul qu'en association avec du serum antirabique,\nsauver les animaux. Meme administres a une dose cor-\nrespondant 'a 140 ml d'un melange de vaccin a 5%, ni le\nvaccin p",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The French summary of the rabies vaccine study, restating that duck-embryo and HEP Flury vaccines protected guinea-pigs poorly compared with pooled phenolized vaccine. It concludes that the recommended human dose of duck-embryo vaccine is inadequate and HEP Flury is unsuited for use after a bite.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-266967/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "REFERENCES",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/sec-018-references.md",
      "narrative": null,
      "content": "Anderson, G. R., Schnurrenberger, P. R., Masterson,\nR. A. & Wentworth, F. H. (1960) Amer. J. Hyg., 71,158\nDean, D.\nJ. & Sherman,\nI. (1962) Publ. Hlth\nRep.\n(Wash.) 77, 705\nFox, J. P. (1958) Ann. N.Y. Acad. Sci., 70, 480\nGreenberg, M. & Childress, J. (1960) J. Amer. med. Ass.,\n173, 333\nHumphrey, G. L., Kemp, G. E. & Wood, E. G. (1960)\nPubl. Hlth Rep. (Wash.), 75, 317\nKaplan, M. M. (1954) Potency-test requirements of United\nStates National Institutes of Health (NIH). In: Labo-\nratory techniques\nin rabies, Geneva,\np.\n117 (World\nHealth Organization: Monograph Series, No. 23)\nKoprowski, H., Black,\nJ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A list of references for the rabies vaccine study, citing mainly work on duck-embryo, HEP Flury and nervous tissue vaccines from 1911 to 1962.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
